Citations

Clear

3314 citation(s) found for "Do, Alexander".

Clinical and Radiographic Features of Giant Cell Arteritis With Intracranial Involvement
Sánchez-Álvarez, Catalina , Hawkins, Alexander S., Koster, Matthew J. , Lehman, Vance T. , Crowson, Cynthia S. , Sanchez-Alvarez, Catalina , Koster, Matthew J , Warrington, Kenneth J.

Mayo Clinic

ACR Open Rheumatology | July 22, 2020 | Volume: 2 | Issue: 8 | Pages: 471-477

10.1002/acr2.11161 | PMID 32697426 Get It

ObjectiveGiant cell arteritis (GCA) is a large‐vessel vasculitis that primarily affects the aorta and its branches. Extracranial branches of the carotid artery are frequently affected; however, intracranial involvement in GCA is rare.MethodsA retrospective medical record review was performed to identify all patients with intracranial GCA (IC‐GCA) from January 1996 through May 2018.ResultsNine patients with IC‐GCA were included (78% male; mean age, 72.1 years [SD: 7.9]). All patients met ACR criteria for GCA. The median time from onset of GCA to intracranial involvement was 0.6 months (interquartile range: 0.1‐5.1). All patients had neurologic symptoms, 89% had an ischemic cerebrovascular event. Transient or permanent vision loss was frequent (56% of patients). IC‐GCA was diagnosed by cranial imaging in all nine patients. Intracranial vasculitis most commonly affected the internal carotid artery (100%), followed by the vertebral artery (67%), posterior cerebral artery (67%), middle cerebral artery (44%), anterior cerebral artery (33%), and posterior inferior cerebral artery (11%). Intracranial vessel stenosis was present in 89%, occlusion in 33%, wall thickening in 33%, and dilation in 11%.All patients received glucocorticoids. Additional therapeutic agents included cyclophosphamide (67%) and tocilizumab (22%). Despite treatment, five patients had rapid deterioration and mortality. Comparing IC‐GCA patient survival to the expected rates from the US population, the standardized mortality ratio (95% CI) for IC‐GCA was 58.1 (18.9‐135.6).ConclusionAlthough rare, IC‐GCA is associated with significant morbidity and mortality. It occurs predominantly in men and presents with ischemic cerebrovascular events. Current treatment strategies appear to be of limited efficacy for IC‐GCA.
A principal component approach to improve association testing with polygenic risk scores
Coombes, Brandon J. , Ploner, Alexander , Bergen, Sarah E. , Biernacka, Joanna M. , Biernacka, Joanna , Coombes, Brandon J

Mayo Clinic

Genetic Epidemiology | July 21, 2020 | Volume: 44 | Issue: 7 | Pages: 676-686

10.1002/gepi.22339 | PMID 32691445 Get It

Abstract Polygenic risk scores (PRSs) have become an increasingly popular approach for demonstrating polygenic influences on complex traits and for establishing common polygenic signals between different traits. PRSs are typically constructed using pruning and thresholding (P+T), but the best choice of parameters is uncertain; thus multiple settings are used and the best is chosen. Optimization can lead to inflated Type I error. Permutation procedures can correct this, but they can be computationally intensive. Alternatively, a single parameter setting can be chosen a priori for the PRS, but choosing suboptimal settings results in loss of power. We propose computing PRSs under a range of parameter settings, performing principal component analysis (PCA) on the resulting set of PRSs, and using the first PRS–PC in association tests. The first PC reweights the variants included in the PRS to achieve maximum variation over all PRS settings used. Using simulations and a real data application to study PRS association with bipolar disorder and psychosis in bipolar disorder, we compare the performance of the proposed PRS–PCA approach with a permutation test and an a priori selected p ‐value threshold. The PRS–PCA approach is simple to implement, outperforms the other strategies in most scenarios, and provides an unbiased estimate of prediction performance.
Does surgical procedure type impact postoperative pain and recovery in deep inferior epigastric artery perforator flap breast reconstruction?
Azizi, Alexander A. , Mohan, Anita T. , Tomouk, Taj , Brickley, Elizabeth B. , Malata, Charles M.

Mayo Clinic

Archives of Plastic Surgery | July 20, 2020 | Volume: 47 | Issue: 04 | Pages: 324-332

10.5999/aps.2019.01417 | PMID 32718111 Get It

Background The deep inferior epigastric artery perforator (DIEP) flap is the commonest flap used for breast reconstruction after mastectomy. It is performed as a unilateral (based on one [unipedicled] or two [bipedicled] vascular pedicles) or bilateral procedure following unilateral or bilateral mastectomies. No previous studies have comprehensively analyzed analgesia requirements and hospital stay of these three forms of surgical reconstruction. Methods A 7-year retrospective cohort study (2008–2015) of a single-surgeon’s DIEP-patients was conducted. Patient-reported pain scores, patient-controlled morphine requirements and recovery times were compared using non-parametric statistics and multivariable regression. Results The study included 135 participants: unilateral unipedicled (n=84), unilateral bipedicled (n=24) and bilateral unipedicled (n=27). Univariate comparison of the three DIEP types showed a significant difference in 12-hour postoperative morphine requirements (P=0.020); bipedicled unilateral patients used significantly less morphine than unipedicled (unilateral) patients at 12 (P=0.005), 24 (P=0.020), and 48 (P=0.046) hours. Multivariable regression comparing these two groups revealed that both reconstruction type and smoking status were significant predictors for 12-hour postoperative morphine usage (P=0.038 and P=0.049, respectively), but only smoking, remained significant at 24 (P=0.010) and 48 (P=0.010) hours. Bilateral reconstruction patients’ mean hospital stay was 2 days longer than either unilateral reconstruction (P<0.001). Conclusions Although all three forms of DIEP flap breast reconstruction had similar postoperative pain measures, a novel finding of our study was that bipedicled DIEP flap harvest might be associated with lower early postoperative morphine requirements. Bilateral and bipedicled procedures in appropriate patients might therefore be undertaken without significantly increased pain/morbidity compared to unilateral unipedicled reconstructions.
Diagnosis of digestive system tumours
Goldberg, Richard M. , Chang, George J. , Lam, Alfred K. , Salto‐Tellez, Manuel , Nagtegaal, Irıs D. , Klimstra, David S. , Rugge, Massimo , Schirmacher, Peter , Odze, Robert D. , Carneiro, Fátima , Fukayama, Masashi , Cree, Ian A. , Board, WHO Classification of Tumours Editorial, Gill, Anthony J. , Limburg, Paul, Lam, Alfred K , Fukayama, Masashi , Cree, Ian , Nagtegaal, Iris D , Washington, Mary Kay , Limburg, Paul J. , Arends, Mark Johan , Lazar, Alexander J. , Board, WHO Classification of Tumours Editorial

Mayo Clinic

International Journal of Cancer | July 16, 2020 | Volume: 148 | Issue: 5 | Pages: 1040-1050

10.1002/ijc.33210 | PMID 32674220 Get It

AbstractThe WHO Classification of Tumours provides the international standards for the classification and diagnosis of tumours. It enables direct comparisons to be made between different countries. In the new fifth edition, the series has gone digital with the launch of a website as well as a series of books, known widely as the WHO Blue Books. The first volume to be produced is on the classification of Digestive System tumours, replacing the successful 2010 version. It has been rewritten and updated accordingly. This article summarises the major diagnostic innovations that have occurred over the last decade and that have now been incorporated in the classification. As an example, it incorporates the recently proposed classification of neuroendocrine tumours, based on the recognition that neuroendocrine tumours and carcinomas differ substantially in the genetic abnormalities that drive their growth, findings relevant to treatment selection and outcome prediction. Several themes have emerged during the production process. One is the importance of the progression from hyperplasia to dysplasia to carcinoma in the evolution of the malignant process. Advances in imaging techniques and endoscopy have resulted in enhanced access to precancerous lesions in the gastrointestinal and biliary tract, necessitating both changes in classification schema and clinical practice. Diagnosis of tumours is no longer the sole purview of pathologists, and some patients now receive treatment before tissue is obtained, based on clinical, radiological and liquid biopsy results. This makes the classification relevant to many disciplines involved in the care of patients with tumours of the digestive system.
Burden of Arrhythmia in Hospitalized HIV Patients
Abudan, Anas , Vaidya, Vaibhav, Tripathi, Byomesh , Egbe, Alexander , Arora, Shilpkumar , Sridhar, Haarini , DeSimone, Christopher V. , Mulpuru, Siva K. , Deshmukh, Abhishek , DeSimone, Christopher V , Noseworthy, Peter A. , DeSimone, Daniel C.

Mayo Clinic

No container title available | July 16, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159493215.58844465 Get It

Background: The improved life expectancy observed in patients living with Human Immunodeficiency Virus (HIV) infection has made age-related cardiovascular complications, including arrhythmias, a growing health concern. We describe the temporal trends in frequency of various arrhythmias and assess impact of arrhythmias on hospitalized HIV patients using the Nationwide Inpatient Sample (NIS) Methods and Results: Data on HIV-related hospitalizations from 2005 to 2014 were obtained from the NIS using International Classification of Diseases, 9th Revision (ICD-9) codes. Data was further subclassified into hospitalizations with associated arrhythmias and those without arrhythmia. Baseline demographics and comorbidities were determined. Outcomes including in-hospital mortality, cost of care, and length of stay were extracted. SAS 9.4 (SAS Institute Inc., Cary, North Carolina) was utilized for analysis. A multivariable analysis was performed to identify predictors of arrhythmias among hospitalized HIV patients. Among 2,370,751 HIV-related hospitalizations identified, the overall frequency of any arrhythmia was 3.01%. Atrial fibrillation (AF) was the most frequent arrhythmia (2110 per 100,000). The overall frequency of arrhythmias has increased over time by 108%, primarily due to a 132% increase in AF. Arrhythmias are more frequent among older males, lowest income quartile and non-elective admissions. Patients with arrhythmias had a higher in-hospital mortality rate (9.6%). In-hospital mortality among patients with arrhythmias has decreased over time by 43.8%. The cost of care and length of stay associated with arrhythmia-related hospitalizations were mostly unchanged. Conclusions: Arrhythmias are associated with significant morbidity and mortality in hospitalized HIV patients. AF is the most frequent arrhythmia in hospitalized HIV patients.
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria
Chang, Alex R. , Wei, Guo , Boucher, Robert E. , Bhatt, Udayan, Cohen, Debbie L. , Drawz, Paul E. , Punzi, Henry , Haley, William E. , Hawfield, Amret , Horwitz, Edward , Morisky, Don, Rocco, Michael V. , Wall, Barry M. , Zias, Athena, Drawz, Paul , Freedman, Barry I , Haley, William E , Rocco, Michael V , Chang, Alexander R , Kramer, Holly , Grams, Morgan Erika , Berlowitz, Dan R. , Freedman, Barry I. , McLouth, Christopher J. , Papademetriou, Vasilios , Weiner, Daniel E. , Beddhu, Srinivasan

Mayo Clinic

Clinical Journal of the American Society of Nephrology | July 15, 2020 | Volume: 15 | Issue: 8 | Pages: 1121-1128

10.2215/cjn.12371019 | PMID 32669306 Get It

Background and objectives It is unclear whether the presence of albuminuria modifies the effects of intensive systolic BP control on risk of eGFR decline, cardiovascular events, or mortality. Design, setting, participants, & measurements The Systolic Blood Pressure Intervention Trial randomized nondiabetic adults ≥50 years of age at high cardiovascular risk to a systolic BP target of <120 or <140 mm Hg, measured by automated office BP. We compared the absolute risk differences and hazard ratios of ≥40% eGFR decline, the Systolic Blood Pressure Intervention Trial primary cardiovascular composite outcome, and all-cause death in those with or without baseline albuminuria (urine albumin-creatinine ratio ≥30 mg/g). Results Over a median follow-up of 3.1 years, 69 of 1723 (4%) participants with baseline albuminuria developed ≥40% eGFR decline compared with 61 of 7162 (1%) participants without albuminuria. Incidence rates of ≥40% eGFR decline were higher in participants with albuminuria (intensive, 1.74 per 100 person-years; standard, 1.17 per 100 person-years) than in participants without albuminuria (intensive, 0.48 per 100 person-years; standard, 0.11 per 100 person-years). Although effects of intensive BP lowering on ≥40% eGFR decline varied by albuminuria on the relative scale (hazard ratio, 1.48; 95% confidence interval, 0.91 to 2.39 for albumin-creatinine ratio ≥30 mg/g; hazard ratio, 4.55; 95% confidence interval, 2.37 to 8.75 for albumin-creatinine ratio <30 mg/g; P value for interaction <0.001), the absolute increase in ≥40% eGFR decline did not differ by baseline albuminuria (incidence difference, 0.38 events per 100 person-years for albumin-creatinine ratio ≥30 mg/g; incidence difference, 0.58 events per 100 person-years for albumin-creatinine ratio <30 mg/g; P value for interaction =0.60). Albuminuria did not significantly modify the beneficial effects of intensive systolic BP lowering on cardiovascular events or mortality evaluated on relative or absolute scales. Conclusions Albuminuria did not modify the absolute benefits and risks of intensive systolic BP lowering.
Cardiovascular outcomes of pregnancy in Turner syndrome
Grewal, Jasmine , Valente, Anne Marie , Egbe, Alexander C. , Wu, Fred , Sybert, Virginia P., Hagen, Iris M. van , Beauchesne, Luc , Rodriguez, Fred H. , Broberg, Craig S. , John, Anitha S. , Bradley, Elisa A. , Roos‐Hesselink, Jolien W. , van Hagen, Iris M , John, Anitha , Roos-Hesselink, Jolien W , Bradley, Elisa A , Krieger, Eric V.

Mayo Clinic

Heart | July 15, 2020 | Volume: 107 | Issue: 1 | Pages: 61-66

10.1136/heartjnl-2020-316719 | PMID 32669396 Get It

Objectives Women with Turner syndrome (TS) are frequently counselled against pregnancy due to lack of data and unclear aortic dissection risk. However, with advances in fertility therapy, more women with TS are contemplating pregnancy. This study compared rates of adverse cardiovascular (CV) outcomes among: (1) pregnant and non-pregnant women with TS and (2) pregnant women with TS with/without structural heart disease. Methods Retrospective analysis of pregnant and age-matched non-pregnant controls with TS (2005–2017) across 10 CV centres was done. Data were collected at initial evaluation in pregnancy and outcomes were assessed to 6 months postpartum. Adverse CV events were defined as CV death, aortic dissection/rupture and/or aortic intervention. Non-pregnant age-matched controls were followed over the same time period. Results Sixty-eight pregnancies were included (60 women, mean age 33 years, 48% primigravid, 49% fertility therapy, 80% structurally normal heart, 25% XO karyotype). Based on American Society of Reproductive Medicine criteria, 10 pregnancies occurred in women stratified to high-risk category. There were no CV events in the pregnant women or in the non-pregnant women with TS. Obstetric events complicated 12 (18%) pregnancies with 9 (13%) attributed to hypertensive disorder of pregnancy. Fetal events included small for gestational age neonates (18%), preterm delivery (15%) and fetal death (3%). Conclusions This study helps to refine the approach to pregnancy in women with TS. Among women with TS without structural heart disease, pregnancy does not impose an increased risk of CV outcomes. Among women with TS with structural heart disease, the risk of pregnancy is not as prohibitive as previously described but does require ongoing evaluation.
Cardiac surgery considerations and lessons learned during the COVID‐19 pandemic
Iribarne, Alexander , Thourani, Vinod H. , Cleveland, Joseph C. , Malaisrie, S. Chris , Romano, Matthew A., Moon, Marc R. , Mewhort, H.E. , Halkos, Michael E. , Sultan, Ibrahim , Kindler, Christine , Firstenberg, Michael S. , Dayan, Víctor , Kasirajan, Vigneshwar , Salerno, Chris, Phillips, Alistair, Sultan, Ibrahim , Ramakrishna, Harish

Mayo Clinic

Journal of Cardiac Surgery | July 15, 2020 | Volume: 35 | Issue: 8 | Pages: 1979-1987

10.1111/jocs.14798 Get It

Palliative care in the emergency department: A survey assessment of patient and provider perspectives
Woods, Emily J , Ginsburg, Alexander , Bellolio, Fernanda , Walker, Laura , Ginsburg, Alexander D, Bellolio, M Fernanda , Ginsburg, Alexander D

Mayo Clinic

Palliative Medicine | July 15, 2020 | Volume: 34 | Issue: 9 | Pages: 1279-1285

10.1177/0269216320942453 | PMID 32666881 Get It

Background: Palliative care has been identified as an area of low outpatient referral from our emergency department, yet palliative care has been shown to improve the quality of patient’s lives. Aim: This study investigates both provider and patient perspectives on palliative care for the purpose of identifying barriers to increased palliative care utilization within our healthcare system. Design: Two surveys were developed, one for patients/caregivers and one for healthcare providers. Setting/participants: This was a single-center study completed at a quaternary academic emergency department. A survey was sent to emergency medicine providers with 47% response rate. Research staff approached Emergency Department patients who had been identified to be high risk to fill out paper surveys with 76% response rate. Results: Only 28% of patients had already undergone palliative care, with an additional 25% interested in palliative care. Nearly half of the patients felt that they needed more resources to prevent hospital visits. Patients identified low understanding of palliative care and difficulty accessing appointments as barriers to consultation. Among providers, 98% indicated that they had patients who would benefit from palliative care. A majority of providers highlighted patient understanding of palliative care and access to appointments as barriers to palliative care. Notably, 52% of providers reported that emergency medicine provider knowledge was a barrier to palliative care consultation. Conclusions: Despite emergency department patients’ self-identified need for resources and emergency medicine providers’ recognition of patients who would benefit from palliative care, few patients receive palliative care consultation.